BIOR(Delisted)
Biora Therapeutics·NASDAQ
--
--(--)
BIOR fundamentals
Biora Therapeutics (BIOR) released its earnings on Aug 13, 2020: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Aug 13, 2020
EPS
Revenue
Revenue & Expenses
BIOR has released its 2024 Q3 earnings report, with revenue of 32.00K, reflecting a YoY change of NaN%, and net profit of -18.40M, showing a YoY change of 74.95%. The Sankey diagram below clearly presents BIOR's revenue sources and cost distribution.
Key Indicators
Biora Therapeutics (BIOR) key financial stats and ratios, covering profitability, financial health, and leverage.
Biora Therapeutics (BIOR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Biora Therapeutics (BIOR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Biora Therapeutics (BIOR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Biora Therapeutics (BIOR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Biora Therapeutics (BIOR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
